Your browser doesn't support javascript.
loading
PARP inhibition in prostate cancer.
Nientiedt, Cathleen; Duensing, Anette; Zschäbitz, Stefanie; Jäger, Dirk; Hohenfellner, Markus; Stenzinger, Albrecht; Duensing, Stefan.
  • Nientiedt C; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
  • Duensing A; Cancer Therapeutics Program, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.
  • Zschäbitz S; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Jäger D; Precision Oncology of Urological Malignancies, Department of Urology, University Hospital Heidelberg, Heidelberg, Germany.
  • Hohenfellner M; Department of Urology, University Hospital Heidelberg, National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Stenzinger A; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
  • Duensing S; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
Genes Chromosomes Cancer ; 60(5): 344-351, 2021 05.
Article en En | MEDLINE | ID: mdl-33084183
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Reparación del ADN / Inhibidores de Poli(ADP-Ribosa) Polimerasas Límite: Animals / Humans / Male Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Reparación del ADN / Inhibidores de Poli(ADP-Ribosa) Polimerasas Límite: Animals / Humans / Male Idioma: En Año: 2021 Tipo del documento: Article